These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36986422)

  • 1. The Global Expansion of LTBI Screening and Treatment Programs: Exploring Gaps in the Supporting Economic Evidence.
    Kota NT; Shrestha S; Kashkary A; Samina P; Zwerling A
    Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.
    Sagili KD; Muniyandi M; Shringarpure K; Singh K; Kirubakaran R; Rao R; Tonsing J; Sachdeva KS; Tharyan P
    Trop Med Int Health; 2022 Oct; 27(10):842-863. PubMed ID: 35927930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review.
    Baggaley RF; Vegvari C; Dimala CA; Lipman M; Miller RF; Brown J; Degtyareva S; White HA; Hollingsworth TD; Pareek M
    Wellcome Open Res; 2021; 6():51. PubMed ID: 37025515
    [No Abstract]   [Full Text] [Related]  

  • 8. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan.
    Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K
    AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment.
    Yoopetch P; Chitpim N; Jittikoon J; Udomsinprasert W; Thavorncharoensap M; Youngkong S; Praditsitthikorn N; Mahasirimongkol S; Chaikledkaew U
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contextualizing and optimizing novel strategies to improve the latent TB continuum of care: Insights from people living with HIV and health care providers in Brazil.
    Salles I; Travassos P; Spener-Gomes R; Loch AP; Saraceni V; Lauria L; Cavalcante S; Garcia de Oliveira J; Brito de Souza A; Guimarães Costa A; Sakabe S; Schiavon Nogueira R; Chaisson LH; Cohn S; Jamal LF; Valdez Ramalho Madruga J; Cordeiro-Santos M; Castro B; Portella Ferreira D; Hoffmann CJ; Golub JE; Durovni B; Kerrigan D
    PLOS Glob Public Health; 2023; 3(1):e0001251. PubMed ID: 36962892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.
    Greenaway C; Pareek M; Abou Chakra CN; Walji M; Makarenko I; Alabdulkarim B; Hogan C; McConnell T; Scarfo B; Christensen R; Tran A; Rowbotham N; van der Werf MJ; Noori T; Pottie K; Matteelli A; Zenner D; Morton RL
    Euro Surveill; 2018 Apr; 23(14):. PubMed ID: 29637889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of TB Infection and Prevention among People Living with HIV.
    Vasiliu A; Abelman R; Kherabi Y; Iswari Saktiawati AM; Kay A
    Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues in expanding latent TB management in high burden countries.
    Basu S; Sharma N; Mase S; Sachdeva KS
    Indian J Med Ethics; 2020; V(1):53-56. PubMed ID: 32103799
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.